Trinity Biotech PLC (TRIB)
1.22
-0.08
(-6.15%)
USD |
NASDAQ |
Nov 22, 12:37
Trinity Biotech Shareholders Equity (Quarterly): -26.34M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -26.34M |
June 30, 2024 | -29.40M |
March 31, 2024 | -22.86M |
December 31, 2023 | -23.95M |
September 30, 2023 | -17.49M |
June 30, 2023 | -11.38M |
March 31, 2023 | -6.618M |
December 31, 2022 | -2.176M |
September 30, 2022 | 6.633M |
June 30, 2022 | 15.82M |
March 31, 2022 | -6.285M |
December 31, 2021 | -0.319M |
September 30, 2021 | 0.81M |
June 30, 2021 | -0.496M |
March 31, 2021 | -0.127M |
December 31, 2020 | -2.219M |
September 30, 2020 | 7.071M |
June 30, 2020 | -0.712M |
March 31, 2020 | 0.768M |
December 31, 2019 | 4.713M |
September 30, 2019 | 38.93M |
June 30, 2019 | 39.07M |
March 31, 2019 | 44.17M |
December 31, 2018 | 44.05M |
September 30, 2018 | 68.08M |
Date | Value |
---|---|
June 30, 2018 | 66.69M |
March 31, 2018 | 65.78M |
December 31, 2017 | 65.20M |
September 30, 2017 | 106.39M |
June 30, 2017 | 106.87M |
March 31, 2017 | 109.28M |
December 31, 2016 | 108.73M |
September 30, 2016 | 210.40M |
June 30, 2016 | 210.66M |
March 31, 2016 | 212.47M |
December 31, 2015 | 213.89M |
September 30, 2015 | 211.00M |
June 30, 2015 | 205.06M |
March 31, 2015 | 201.24M |
December 31, 2014 | 196.97M |
September 30, 2014 | 194.78M |
June 30, 2014 | 196.11M |
March 31, 2014 | 189.01M |
December 31, 2013 | 183.01M |
September 30, 2013 | 175.13M |
June 30, 2013 | 174.82M |
March 31, 2013 | 174.61M |
December 31, 2012 | 169.38M |
September 30, 2012 | 165.06M |
June 30, 2012 | 159.68M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-29.40M
Minimum
Jun 2024
15.82M
Maximum
Jun 2022
-5.728M
Average
-1.444M
Median
Shareholders Equity (Quarterly) Benchmarks
Amarin Corp PLC | 531.38M |
DBV Technologies SA | 54.03M |
Ascendis Pharma AS | -108.70M |
Cellectis SA | 129.42M |
Adaptimmune Therapeutics PLC | 79.99M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 97.45M |
Total Liabilities (Quarterly) | 123.79M |
Debt to Equity Ratio | -3.106 |
Current Ratio | 1.642 |
Net Debt Paydown Yield | -53.20% |